Drug class in one race
ANGPTL3 drugs for Atherosclerotic Cardiovascular Disease
10 tracked ANGPTL3 drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the ANGPTL3 page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
1 Phase 35 Phase 24 Phase 1
Head-to-head evidence: ALN-ANG3 vs EDP167 · ALN-ANG3 vs Evinacumab · ALN-ANG3 vs HRS-7249 · ALN-ANG3 vs NNC0491-6075 · ALN-ANG3 vs Solbinsiran · AZD1705 vs EDP167